Global Almonertinib Mesylate Supply, Demand and Key Producers, 2026-2032
The global Almonertinib Mesylate market size is expected to reach $ 700 million by 2032, rising at a market growth of 17.4% CAGR during the forecast period (2026-2032).
In 2025, global production of almonertinib mesilate reached approximately 1.02 million units.Almonertinib Mesylate is an oral third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), primarily used for the treatment of patients with non-small cell lung cancer (NSCLC) harboring EGFR-sensitive mutations or the T790M resistance mutation. It works by selectively inhibiting the kinase activity of mutant EGFR, thereby blocking tumor cell proliferation and survival signaling pathways and suppressing tumor growth.
Almonertinib mesylate is characterized by high selectivity for mutant EGFR, good central nervous system penetration, and a relatively manageable safety profile, making it clinically valuable in the treatment of advanced non-small cell lung cancer.
Almonertinib Mesylate, as a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), operates in a rapidly evolving segment of the non-small cell lung cancer (NSCLC) targeted therapy market, particularly demonstrating strong competitiveness in patients with EGFR mutations and T790M resistance mutations. With the large population of lung cancer patients and the continuous improvement in genetic testing penetration, the demand for precision therapy is steadily increasing, providing a solid market foundation for this class of drugs.
From a competitive landscape perspective, imported originator drugs represented by Osimertinib have long dominated the market. However, almonertinib mesylate, leveraging its domestic R&D advantages, competitive pricing, and potential efficacy in patients with central nervous system metastases, is gradually gaining market share in China.
On the policy side, its inclusion in the national reimbursement drug list helps improve patient accessibility and promote market expansion, although healthcare cost-control measures and volume-based procurement policies continue to exert pressure on pricing. From a competitive standpoint, multiple third-generation EGFR-TKIs and next-generation targeted therapies from both domestic and international companies are continuously entering the market, intensifying competition. Therefore, the future market performance of almonertinib mesylate will depend on its penetration in first-line treatment, expansion of indications (such as adjuvant therapy), and the accumulation of real-world evidence, as well as its overall competitive balance in terms of efficacy, safety, and pricing.
This report studies the global Almonertinib Mesylate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Almonertinib Mesylate and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Almonertinib Mesylate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Almonertinib Mesylate total production and demand, 2021-2032, (Units)
Global Almonertinib Mesylate total production value, 2021-2032, (USD Million)
Global Almonertinib Mesylate production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Almonertinib Mesylate consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Almonertinib Mesylate domestic production, consumption, key domestic manufacturers and share
Global Almonertinib Mesylate production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Almonertinib Mesylate production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Almonertinib Mesylate production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Almonertinib Mesylate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Hansoh Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Almonertinib Mesylate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Almonertinib Mesylate Market, By Region:
1. How big is the global Almonertinib Mesylate market?
2. What is the demand of the global Almonertinib Mesylate market?
3. What is the year over year growth of the global Almonertinib Mesylate market?
4. What is the production and production value of the global Almonertinib Mesylate market?
5. Who are the key producers in the global Almonertinib Mesylate market?
6. What are the growth factors driving the market demand?
In 2025, global production of almonertinib mesilate reached approximately 1.02 million units.Almonertinib Mesylate is an oral third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), primarily used for the treatment of patients with non-small cell lung cancer (NSCLC) harboring EGFR-sensitive mutations or the T790M resistance mutation. It works by selectively inhibiting the kinase activity of mutant EGFR, thereby blocking tumor cell proliferation and survival signaling pathways and suppressing tumor growth.
Almonertinib mesylate is characterized by high selectivity for mutant EGFR, good central nervous system penetration, and a relatively manageable safety profile, making it clinically valuable in the treatment of advanced non-small cell lung cancer.
Almonertinib Mesylate, as a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), operates in a rapidly evolving segment of the non-small cell lung cancer (NSCLC) targeted therapy market, particularly demonstrating strong competitiveness in patients with EGFR mutations and T790M resistance mutations. With the large population of lung cancer patients and the continuous improvement in genetic testing penetration, the demand for precision therapy is steadily increasing, providing a solid market foundation for this class of drugs.
From a competitive landscape perspective, imported originator drugs represented by Osimertinib have long dominated the market. However, almonertinib mesylate, leveraging its domestic R&D advantages, competitive pricing, and potential efficacy in patients with central nervous system metastases, is gradually gaining market share in China.
On the policy side, its inclusion in the national reimbursement drug list helps improve patient accessibility and promote market expansion, although healthcare cost-control measures and volume-based procurement policies continue to exert pressure on pricing. From a competitive standpoint, multiple third-generation EGFR-TKIs and next-generation targeted therapies from both domestic and international companies are continuously entering the market, intensifying competition. Therefore, the future market performance of almonertinib mesylate will depend on its penetration in first-line treatment, expansion of indications (such as adjuvant therapy), and the accumulation of real-world evidence, as well as its overall competitive balance in terms of efficacy, safety, and pricing.
This report studies the global Almonertinib Mesylate production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Almonertinib Mesylate and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Almonertinib Mesylate that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Almonertinib Mesylate total production and demand, 2021-2032, (Units)
Global Almonertinib Mesylate total production value, 2021-2032, (USD Million)
Global Almonertinib Mesylate production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Almonertinib Mesylate consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Almonertinib Mesylate domestic production, consumption, key domestic manufacturers and share
Global Almonertinib Mesylate production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Almonertinib Mesylate production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Almonertinib Mesylate production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Almonertinib Mesylate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Hansoh Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Almonertinib Mesylate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Almonertinib Mesylate Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 55mg
- 110mg
- Non-small Cell Lung Cancer (NSCLC)
- Third-generation Tyrosine Kinase Inhibitor (TKI)
- Others
- Jiangsu Hansoh Pharmaceutical Group
1. How big is the global Almonertinib Mesylate market?
2. What is the demand of the global Almonertinib Mesylate market?
3. What is the year over year growth of the global Almonertinib Mesylate market?
4. What is the production and production value of the global Almonertinib Mesylate market?
5. Who are the key producers in the global Almonertinib Mesylate market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Almonertinib Mesylate Introduction
1.2 World Almonertinib Mesylate Supply & Forecast
1.2.1 World Almonertinib Mesylate Production Value (2021 & 2025 & 2032)
1.2.2 World Almonertinib Mesylate Production (2021-2032)
1.2.3 World Almonertinib Mesylate Pricing Trends (2021-2032)
1.3 World Almonertinib Mesylate Production by Region (Based on Production Site)
1.3.1 World Almonertinib Mesylate Production Value by Region (2021-2032)
1.3.2 World Almonertinib Mesylate Production by Region (2021-2032)
1.3.3 World Almonertinib Mesylate Average Price by Region (2021-2032)
1.3.4 North America Almonertinib Mesylate Production (2021-2032)
1.3.5 Europe Almonertinib Mesylate Production (2021-2032)
1.3.6 China Almonertinib Mesylate Production (2021-2032)
1.3.7 Japan Almonertinib Mesylate Production (2021-2032)
1.3.8 India Almonertinib Mesylate Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Almonertinib Mesylate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Almonertinib Mesylate Major Market Trends
2 DEMAND SUMMARY
2.1 World Almonertinib Mesylate Demand (2021-2032)
2.2 World Almonertinib Mesylate Consumption by Region
2.2.1 World Almonertinib Mesylate Consumption by Region (2021-2026)
2.2.2 World Almonertinib Mesylate Consumption Forecast by Region (2027-2032)
2.3 United States Almonertinib Mesylate Consumption (2021-2032)
2.4 China Almonertinib Mesylate Consumption (2021-2032)
2.5 Europe Almonertinib Mesylate Consumption (2021-2032)
2.6 Japan Almonertinib Mesylate Consumption (2021-2032)
2.7 South Korea Almonertinib Mesylate Consumption (2021-2032)
2.8 ASEAN Almonertinib Mesylate Consumption (2021-2032)
2.9 India Almonertinib Mesylate Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Almonertinib Mesylate Production Value by Manufacturer (2021-2026)
3.2 World Almonertinib Mesylate Production by Manufacturer (2021-2026)
3.3 World Almonertinib Mesylate Average Price by Manufacturer (2021-2026)
3.4 Almonertinib Mesylate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Almonertinib Mesylate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Almonertinib Mesylate in 2025
3.5.3 Global Concentration Ratios (CR8) for Almonertinib Mesylate in 2025
3.6 Almonertinib Mesylate Market: Overall Company Footprint Analysis
3.6.1 Almonertinib Mesylate Market: Region Footprint
3.6.2 Almonertinib Mesylate Market: Company Product Type Footprint
3.6.3 Almonertinib Mesylate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Almonertinib Mesylate Production Value Comparison
4.1.1 United States VS China: Almonertinib Mesylate Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Almonertinib Mesylate Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Almonertinib Mesylate Production Comparison
4.2.1 United States VS China: Almonertinib Mesylate Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Almonertinib Mesylate Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Almonertinib Mesylate Consumption Comparison
4.3.1 United States VS China: Almonertinib Mesylate Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Almonertinib Mesylate Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Almonertinib Mesylate Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Almonertinib Mesylate Production Value (2021-2026)
4.4.3 United States Based Manufacturers Almonertinib Mesylate Production (2021-2026)
4.5 China Based Almonertinib Mesylate Manufacturers and Market Share
4.5.1 China Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Almonertinib Mesylate Production Value (2021-2026)
4.5.3 China Based Manufacturers Almonertinib Mesylate Production (2021-2026)
4.6 Rest of World Based Almonertinib Mesylate Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Almonertinib Mesylate Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Almonertinib Mesylate Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Almonertinib Mesylate Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 55mg
5.2.2 110mg
5.3 Market Segment by Type
5.3.1 World Almonertinib Mesylate Production by Type (2021-2032)
5.3.2 World Almonertinib Mesylate Production Value by Type (2021-2032)
5.3.3 World Almonertinib Mesylate Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Almonertinib Mesylate Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Non-small Cell Lung Cancer (NSCLC)
6.2.2 Third-generation Tyrosine Kinase Inhibitor (TKI)
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Almonertinib Mesylate Production by Application (2021-2032)
6.3.2 World Almonertinib Mesylate Production Value by Application (2021-2032)
6.3.3 World Almonertinib Mesylate Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Jiangsu Hansoh Pharmaceutical Group
7.1.1 Jiangsu Hansoh Pharmaceutical Group Details
7.1.2 Jiangsu Hansoh Pharmaceutical Group Major Business
7.1.3 Jiangsu Hansoh Pharmaceutical Group Almonertinib Mesylate Product and Services
7.1.4 Jiangsu Hansoh Pharmaceutical Group Almonertinib Mesylate Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments/Updates
7.1.6 Jiangsu Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Almonertinib Mesylate Industry Chain
8.2 Almonertinib Mesylate Upstream Analysis
8.2.1 Almonertinib Mesylate Core Raw Materials
8.2.2 Main Manufacturers of Almonertinib Mesylate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Almonertinib Mesylate Production Mode
8.6 Almonertinib Mesylate Procurement Model
8.7 Almonertinib Mesylate Industry Sales Model and Sales Channels
8.7.1 Almonertinib Mesylate Sales Model
8.7.2 Almonertinib Mesylate Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Almonertinib Mesylate Introduction
1.2 World Almonertinib Mesylate Supply & Forecast
1.2.1 World Almonertinib Mesylate Production Value (2021 & 2025 & 2032)
1.2.2 World Almonertinib Mesylate Production (2021-2032)
1.2.3 World Almonertinib Mesylate Pricing Trends (2021-2032)
1.3 World Almonertinib Mesylate Production by Region (Based on Production Site)
1.3.1 World Almonertinib Mesylate Production Value by Region (2021-2032)
1.3.2 World Almonertinib Mesylate Production by Region (2021-2032)
1.3.3 World Almonertinib Mesylate Average Price by Region (2021-2032)
1.3.4 North America Almonertinib Mesylate Production (2021-2032)
1.3.5 Europe Almonertinib Mesylate Production (2021-2032)
1.3.6 China Almonertinib Mesylate Production (2021-2032)
1.3.7 Japan Almonertinib Mesylate Production (2021-2032)
1.3.8 India Almonertinib Mesylate Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Almonertinib Mesylate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Almonertinib Mesylate Major Market Trends
2 DEMAND SUMMARY
2.1 World Almonertinib Mesylate Demand (2021-2032)
2.2 World Almonertinib Mesylate Consumption by Region
2.2.1 World Almonertinib Mesylate Consumption by Region (2021-2026)
2.2.2 World Almonertinib Mesylate Consumption Forecast by Region (2027-2032)
2.3 United States Almonertinib Mesylate Consumption (2021-2032)
2.4 China Almonertinib Mesylate Consumption (2021-2032)
2.5 Europe Almonertinib Mesylate Consumption (2021-2032)
2.6 Japan Almonertinib Mesylate Consumption (2021-2032)
2.7 South Korea Almonertinib Mesylate Consumption (2021-2032)
2.8 ASEAN Almonertinib Mesylate Consumption (2021-2032)
2.9 India Almonertinib Mesylate Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Almonertinib Mesylate Production Value by Manufacturer (2021-2026)
3.2 World Almonertinib Mesylate Production by Manufacturer (2021-2026)
3.3 World Almonertinib Mesylate Average Price by Manufacturer (2021-2026)
3.4 Almonertinib Mesylate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Almonertinib Mesylate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Almonertinib Mesylate in 2025
3.5.3 Global Concentration Ratios (CR8) for Almonertinib Mesylate in 2025
3.6 Almonertinib Mesylate Market: Overall Company Footprint Analysis
3.6.1 Almonertinib Mesylate Market: Region Footprint
3.6.2 Almonertinib Mesylate Market: Company Product Type Footprint
3.6.3 Almonertinib Mesylate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Almonertinib Mesylate Production Value Comparison
4.1.1 United States VS China: Almonertinib Mesylate Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Almonertinib Mesylate Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Almonertinib Mesylate Production Comparison
4.2.1 United States VS China: Almonertinib Mesylate Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Almonertinib Mesylate Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Almonertinib Mesylate Consumption Comparison
4.3.1 United States VS China: Almonertinib Mesylate Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Almonertinib Mesylate Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Almonertinib Mesylate Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Almonertinib Mesylate Production Value (2021-2026)
4.4.3 United States Based Manufacturers Almonertinib Mesylate Production (2021-2026)
4.5 China Based Almonertinib Mesylate Manufacturers and Market Share
4.5.1 China Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Almonertinib Mesylate Production Value (2021-2026)
4.5.3 China Based Manufacturers Almonertinib Mesylate Production (2021-2026)
4.6 Rest of World Based Almonertinib Mesylate Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Almonertinib Mesylate Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Almonertinib Mesylate Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Almonertinib Mesylate Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 55mg
5.2.2 110mg
5.3 Market Segment by Type
5.3.1 World Almonertinib Mesylate Production by Type (2021-2032)
5.3.2 World Almonertinib Mesylate Production Value by Type (2021-2032)
5.3.3 World Almonertinib Mesylate Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Almonertinib Mesylate Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Non-small Cell Lung Cancer (NSCLC)
6.2.2 Third-generation Tyrosine Kinase Inhibitor (TKI)
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Almonertinib Mesylate Production by Application (2021-2032)
6.3.2 World Almonertinib Mesylate Production Value by Application (2021-2032)
6.3.3 World Almonertinib Mesylate Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Jiangsu Hansoh Pharmaceutical Group
7.1.1 Jiangsu Hansoh Pharmaceutical Group Details
7.1.2 Jiangsu Hansoh Pharmaceutical Group Major Business
7.1.3 Jiangsu Hansoh Pharmaceutical Group Almonertinib Mesylate Product and Services
7.1.4 Jiangsu Hansoh Pharmaceutical Group Almonertinib Mesylate Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments/Updates
7.1.6 Jiangsu Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Almonertinib Mesylate Industry Chain
8.2 Almonertinib Mesylate Upstream Analysis
8.2.1 Almonertinib Mesylate Core Raw Materials
8.2.2 Main Manufacturers of Almonertinib Mesylate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Almonertinib Mesylate Production Mode
8.6 Almonertinib Mesylate Procurement Model
8.7 Almonertinib Mesylate Industry Sales Model and Sales Channels
8.7.1 Almonertinib Mesylate Sales Model
8.7.2 Almonertinib Mesylate Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Almonertinib Mesylate Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Almonertinib Mesylate Production Value by Region (2021-2026) & (USD Million)
Table 3. World Almonertinib Mesylate Production Value by Region (2027-2032) & (USD Million)
Table 4. World Almonertinib Mesylate Production Value Market Share by Region (2021-2026)
Table 5. World Almonertinib Mesylate Production Value Market Share by Region (2027-2032)
Table 6. World Almonertinib Mesylate Production by Region (2021-2026) & (Units)
Table 7. World Almonertinib Mesylate Production by Region (2027-2032) & (Units)
Table 8. World Almonertinib Mesylate Production Market Share by Region (2021-2026)
Table 9. World Almonertinib Mesylate Production Market Share by Region (2027-2032)
Table 10. World Almonertinib Mesylate Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Almonertinib Mesylate Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Almonertinib Mesylate Major Market Trends
Table 13. World Almonertinib Mesylate Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Almonertinib Mesylate Consumption by Region (2021-2026) & (Units)
Table 15. World Almonertinib Mesylate Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Almonertinib Mesylate Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Almonertinib Mesylate Producers in 2025
Table 18. World Almonertinib Mesylate Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Almonertinib Mesylate Producers in 2025
Table 20. World Almonertinib Mesylate Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Almonertinib Mesylate Company Evaluation Quadrant
Table 22. World Almonertinib Mesylate Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Almonertinib Mesylate Production Site of Key Manufacturer
Table 24. Almonertinib Mesylate Market: Company Product Type Footprint
Table 25. Almonertinib Mesylate Market: Company Product Application Footprint
Table 26. Almonertinib Mesylate Competitive Factors
Table 27. Almonertinib Mesylate New Entrant and Capacity Expansion Plans
Table 28. Almonertinib Mesylate Mergers & Acquisitions Activity
Table 29. United States VS China Almonertinib Mesylate Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Almonertinib Mesylate Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Almonertinib Mesylate Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Almonertinib Mesylate Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Almonertinib Mesylate Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Almonertinib Mesylate Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Almonertinib Mesylate Production Market Share (2021-2026)
Table 37. China Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Almonertinib Mesylate Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Almonertinib Mesylate Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Almonertinib Mesylate Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Almonertinib Mesylate Production Market Share (2021-2026)
Table 42. Rest of World Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Almonertinib Mesylate Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Almonertinib Mesylate Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Almonertinib Mesylate Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Almonertinib Mesylate Production Market Share (2021-2026)
Table 47. World Almonertinib Mesylate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Almonertinib Mesylate Production by Type (2021-2026) & (Units)
Table 49. World Almonertinib Mesylate Production by Type (2027-2032) & (Units)
Table 50. World Almonertinib Mesylate Production Value by Type (2021-2026) & (USD Million)
Table 51. World Almonertinib Mesylate Production Value by Type (2027-2032) & (USD Million)
Table 52. World Almonertinib Mesylate Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Almonertinib Mesylate Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Almonertinib Mesylate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Almonertinib Mesylate Production by Application (2021-2026) & (Units)
Table 56. World Almonertinib Mesylate Production by Application (2027-2032) & (Units)
Table 57. World Almonertinib Mesylate Production Value by Application (2021-2026) & (USD Million)
Table 58. World Almonertinib Mesylate Production Value by Application (2027-2032) & (USD Million)
Table 59. World Almonertinib Mesylate Average Price by Application (2021-2026) & (US$/Unit)
Table 60. World Almonertinib Mesylate Average Price by Application (2027-2032) & (US$/Unit)
Table 61. Jiangsu Hansoh Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 62. Jiangsu Hansoh Pharmaceutical Group Major Business
Table 63. Jiangsu Hansoh Pharmaceutical Group Almonertinib Mesylate Product and Services
Table 64. Jiangsu Hansoh Pharmaceutical Group Almonertinib Mesylate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Jiangsu Hansoh Pharmaceutical Group Recent Developments/Updates
Table 66. Jiangsu Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
Table 67. Global Key Players of Almonertinib Mesylate Upstream (Raw Materials)
Table 68. Global Almonertinib Mesylate Typical Customers
Table 69. Almonertinib Mesylate Typical Distributors
Table 1. World Almonertinib Mesylate Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Almonertinib Mesylate Production Value by Region (2021-2026) & (USD Million)
Table 3. World Almonertinib Mesylate Production Value by Region (2027-2032) & (USD Million)
Table 4. World Almonertinib Mesylate Production Value Market Share by Region (2021-2026)
Table 5. World Almonertinib Mesylate Production Value Market Share by Region (2027-2032)
Table 6. World Almonertinib Mesylate Production by Region (2021-2026) & (Units)
Table 7. World Almonertinib Mesylate Production by Region (2027-2032) & (Units)
Table 8. World Almonertinib Mesylate Production Market Share by Region (2021-2026)
Table 9. World Almonertinib Mesylate Production Market Share by Region (2027-2032)
Table 10. World Almonertinib Mesylate Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Almonertinib Mesylate Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Almonertinib Mesylate Major Market Trends
Table 13. World Almonertinib Mesylate Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Almonertinib Mesylate Consumption by Region (2021-2026) & (Units)
Table 15. World Almonertinib Mesylate Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Almonertinib Mesylate Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Almonertinib Mesylate Producers in 2025
Table 18. World Almonertinib Mesylate Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Almonertinib Mesylate Producers in 2025
Table 20. World Almonertinib Mesylate Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Almonertinib Mesylate Company Evaluation Quadrant
Table 22. World Almonertinib Mesylate Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Almonertinib Mesylate Production Site of Key Manufacturer
Table 24. Almonertinib Mesylate Market: Company Product Type Footprint
Table 25. Almonertinib Mesylate Market: Company Product Application Footprint
Table 26. Almonertinib Mesylate Competitive Factors
Table 27. Almonertinib Mesylate New Entrant and Capacity Expansion Plans
Table 28. Almonertinib Mesylate Mergers & Acquisitions Activity
Table 29. United States VS China Almonertinib Mesylate Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Almonertinib Mesylate Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Almonertinib Mesylate Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Almonertinib Mesylate Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Almonertinib Mesylate Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Almonertinib Mesylate Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Almonertinib Mesylate Production Market Share (2021-2026)
Table 37. China Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Almonertinib Mesylate Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Almonertinib Mesylate Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Almonertinib Mesylate Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Almonertinib Mesylate Production Market Share (2021-2026)
Table 42. Rest of World Based Almonertinib Mesylate Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Almonertinib Mesylate Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Almonertinib Mesylate Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Almonertinib Mesylate Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Almonertinib Mesylate Production Market Share (2021-2026)
Table 47. World Almonertinib Mesylate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Almonertinib Mesylate Production by Type (2021-2026) & (Units)
Table 49. World Almonertinib Mesylate Production by Type (2027-2032) & (Units)
Table 50. World Almonertinib Mesylate Production Value by Type (2021-2026) & (USD Million)
Table 51. World Almonertinib Mesylate Production Value by Type (2027-2032) & (USD Million)
Table 52. World Almonertinib Mesylate Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Almonertinib Mesylate Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Almonertinib Mesylate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Almonertinib Mesylate Production by Application (2021-2026) & (Units)
Table 56. World Almonertinib Mesylate Production by Application (2027-2032) & (Units)
Table 57. World Almonertinib Mesylate Production Value by Application (2021-2026) & (USD Million)
Table 58. World Almonertinib Mesylate Production Value by Application (2027-2032) & (USD Million)
Table 59. World Almonertinib Mesylate Average Price by Application (2021-2026) & (US$/Unit)
Table 60. World Almonertinib Mesylate Average Price by Application (2027-2032) & (US$/Unit)
Table 61. Jiangsu Hansoh Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 62. Jiangsu Hansoh Pharmaceutical Group Major Business
Table 63. Jiangsu Hansoh Pharmaceutical Group Almonertinib Mesylate Product and Services
Table 64. Jiangsu Hansoh Pharmaceutical Group Almonertinib Mesylate Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Jiangsu Hansoh Pharmaceutical Group Recent Developments/Updates
Table 66. Jiangsu Hansoh Pharmaceutical Group Competitive Strengths & Weaknesses
Table 67. Global Key Players of Almonertinib Mesylate Upstream (Raw Materials)
Table 68. Global Almonertinib Mesylate Typical Customers
Table 69. Almonertinib Mesylate Typical Distributors
LIST OF FIGURES
Figure 1. Almonertinib Mesylate Picture
Figure 2. World Almonertinib Mesylate Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Almonertinib Mesylate Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 5. World Almonertinib Mesylate Average Price (2021-2032) & (US$/Unit)
Figure 6. World Almonertinib Mesylate Production Value Market Share by Region (2021-2032)
Figure 7. World Almonertinib Mesylate Production Market Share by Region (2021-2032)
Figure 8. North America Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 9. Europe Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 10. China Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 11. Japan Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 12. India Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 13. Almonertinib Mesylate Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 16. World Almonertinib Mesylate Consumption Market Share by Region (2021-2032)
Figure 17. United States Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 18. China Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 19. Europe Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 20. Japan Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 21. South Korea Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 22. ASEAN Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 23. India Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Almonertinib Mesylate by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Almonertinib Mesylate Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Almonertinib Mesylate Markets in 2025
Figure 27. United States VS China: Almonertinib Mesylate Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Almonertinib Mesylate Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Almonertinib Mesylate Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Almonertinib Mesylate Production Market Share 2025
Figure 31. China Based Manufacturers Almonertinib Mesylate Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Almonertinib Mesylate Production Market Share 2025
Figure 33. World Almonertinib Mesylate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Almonertinib Mesylate Production Value Market Share by Type in 2025
Figure 35. 55mg
Figure 36. 110mg
Figure 37. World Almonertinib Mesylate Production Market Share by Type (2021-2032)
Figure 38. World Almonertinib Mesylate Production Value Market Share by Type (2021-2032)
Figure 39. World Almonertinib Mesylate Average Price by Type (2021-2032) & (US$/Unit)
Figure 40.Tablets
Figure 41. Powder
Figure 42. Hospital
Figure 43. Retail
Figure 44. Online
Figure 45. World Almonertinib Mesylate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Almonertinib Mesylate Production Value Market Share by Application in 2025
Figure 47. Non-small Cell Lung Cancer (NSCLC)
Figure 48. Third-generation Tyrosine Kinase Inhibitor (TKI)
Figure 49. Others
Figure 50. World Almonertinib Mesylate Production Market Share by Application (2021-2032)
Figure 51. World Almonertinib Mesylate Production Value Market Share by Application (2021-2032)
Figure 52. World Almonertinib Mesylate Average Price by Application (2021-2032) & (US$/Unit)
Figure 53. Almonertinib Mesylate Industry Chain
Figure 54. Almonertinib Mesylate Procurement Model
Figure 55. Almonertinib Mesylate Sales Model
Figure 56. Almonertinib Mesylate Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. Almonertinib Mesylate Picture
Figure 2. World Almonertinib Mesylate Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Almonertinib Mesylate Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 5. World Almonertinib Mesylate Average Price (2021-2032) & (US$/Unit)
Figure 6. World Almonertinib Mesylate Production Value Market Share by Region (2021-2032)
Figure 7. World Almonertinib Mesylate Production Market Share by Region (2021-2032)
Figure 8. North America Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 9. Europe Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 10. China Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 11. Japan Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 12. India Almonertinib Mesylate Production (2021-2032) & (Units)
Figure 13. Almonertinib Mesylate Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 16. World Almonertinib Mesylate Consumption Market Share by Region (2021-2032)
Figure 17. United States Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 18. China Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 19. Europe Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 20. Japan Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 21. South Korea Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 22. ASEAN Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 23. India Almonertinib Mesylate Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Almonertinib Mesylate by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Almonertinib Mesylate Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Almonertinib Mesylate Markets in 2025
Figure 27. United States VS China: Almonertinib Mesylate Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Almonertinib Mesylate Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Almonertinib Mesylate Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Almonertinib Mesylate Production Market Share 2025
Figure 31. China Based Manufacturers Almonertinib Mesylate Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Almonertinib Mesylate Production Market Share 2025
Figure 33. World Almonertinib Mesylate Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Almonertinib Mesylate Production Value Market Share by Type in 2025
Figure 35. 55mg
Figure 36. 110mg
Figure 37. World Almonertinib Mesylate Production Market Share by Type (2021-2032)
Figure 38. World Almonertinib Mesylate Production Value Market Share by Type (2021-2032)
Figure 39. World Almonertinib Mesylate Average Price by Type (2021-2032) & (US$/Unit)
Figure 40.Tablets
Figure 41. Powder
Figure 42. Hospital
Figure 43. Retail
Figure 44. Online
Figure 45. World Almonertinib Mesylate Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 46. World Almonertinib Mesylate Production Value Market Share by Application in 2025
Figure 47. Non-small Cell Lung Cancer (NSCLC)
Figure 48. Third-generation Tyrosine Kinase Inhibitor (TKI)
Figure 49. Others
Figure 50. World Almonertinib Mesylate Production Market Share by Application (2021-2032)
Figure 51. World Almonertinib Mesylate Production Value Market Share by Application (2021-2032)
Figure 52. World Almonertinib Mesylate Average Price by Application (2021-2032) & (US$/Unit)
Figure 53. Almonertinib Mesylate Industry Chain
Figure 54. Almonertinib Mesylate Procurement Model
Figure 55. Almonertinib Mesylate Sales Model
Figure 56. Almonertinib Mesylate Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
